Senestech, Inc. (SNES) Downgraded by Zacks Investment Research
Senestech, Inc. (NASDAQ:SNES) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Friday.
According to Zacks, “SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company’s fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona. “
Shares of Senestech (NASDAQ SNES) traded down 12.86% on Friday, hitting $1.83. The stock had a trading volume of 118,608 shares. Senestech has a 52-week low of $1.83 and a 52-week high of $10.69. The firm’s 50-day moving average price is $2.05 and its 200 day moving average price is $4.83. The firm’s market cap is $18.89 million.
Senestech (NASDAQ:SNES) last announced its earnings results on Thursday, August 10th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.07). The company had revenue of $0.01 million during the quarter, compared to analysts’ expectations of $0.10 million. On average, equities research analysts predict that Senestech will post ($1.30) EPS for the current year.
In related news, Director Grover T. Wickersham acquired 15,000 shares of the firm’s stock in a transaction on Tuesday, July 25th. The stock was bought at an average cost of $2.85 per share, with a total value of $42,750.00. Following the transaction, the director now owns 238,600 shares of the company’s stock, valued at $680,010. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Andrew Altman acquired 20,000 shares of the firm’s stock in a transaction on Friday, August 18th. The shares were bought at an average cost of $2.77 per share, with a total value of $55,400.00. Following the completion of the transaction, the chief operating officer now directly owns 2,600 shares in the company, valued at approximately $7,202. The disclosure for this purchase can be found here. Over the last ninety days, insiders have acquired 54,100 shares of company stock valued at $155,730 and have sold 13,411 shares valued at $35,333. 27.40% of the stock is currently owned by company insiders.
An institutional investor recently bought a new position in Senestech stock. White Pine Capital LLC acquired a new position in shares of Senestech, Inc. (NASDAQ:SNES) in the second quarter, according to its most recent disclosure with the SEC. The firm acquired 19,250 shares of the company’s stock, valued at approximately $110,000. White Pine Capital LLC owned 0.19% of Senestech at the end of the most recent quarter. 15.34% of the stock is owned by institutional investors and hedge funds.
Senestech Company Profile
SenesTech, Inc is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest’s technology and approach targets the reproductive capabilities of both sexes.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Senestech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech Inc. and related companies with MarketBeat.com's FREE daily email newsletter.